Galena Biopharma, Inc. (GALE) stock prices updated...

Galena Biopharma, Inc. stock price

Galena Biopharma, Inc. latest news:

  • 11/09/2017 15:49:52

    BRIEF-Galena Biopharma posts Q3 loss $0.15/shr from continuing operations

    Galena Biopharma Inc(GALE). * Galena Biopharma(GALE) reports third quarter 2017 financial results. * Q3 loss per share $0.15 from continuing operations. * Galena Biopharma Inc (GALE) - ‍cash and cash equivalents of approximately $12.9 million as of September 30, 2017, compared with $18.1 million as of December 31, 2016​ Source text for Eikon: Further company coverage:

  • 09/08/2017 14:02:02

    Galena settles U.S. kickback charges related to opioid drug

    Galena Biopharma Inc(GALE) will pay more than $7.55 million to resolve charges it paid kickbacks to doctors to induce them to prescribe its opioid-based pain medication Abstral to patients, the U.S. Department of Justice said on Friday. The settlement with Galena comes as federal authorities try to combat an epidemic of opioid abuse, which President Donald Trump last month declared a national emergency.

  • More trends:

    Galmed Pharmaceuticals Ltd.GLMD | Gaming and Leisure Properties, Inc.GLPI | Gaming Partners International CorporationGPIC | Garmin Ltd.GRMN | Garnero Group Acquisition CompanyGGAC | Garnero Group Acquisition CompanyGGACR | Garnero Group Acquisition CompanyGGACU | Garnero Group Acquisition CompanyGGACW | Garrison Capital Inc.GARS | Gencor Industries Inc.GENC |